Gastromed S.R.L.
- Address
- Strada Bucuresti 21, 900161 Constanța, Romania
Gastromed S.R.L. - Inflammatory Bowel Disease Research Center
Gastromed S.R.L. is a specialized clinical research center with extensive expertise in inflammatory bowel disease (IBD) therapeutics. The center demonstrates deep experience in conducting complex Phase II and Phase III studies evaluating novel treatment approaches for both ulcerative colitis and Crohn's disease, ranging from innovative drug delivery systems to biosimilar evaluations and next-generation biologics.
- Ulcerative colitis clinical trials across disease severity spectrum, from mild to moderate left-sided disease to moderately to severely active presentations
- Biosimilar comparability studies for advanced IBD biologics
- Novel therapeutic development including targeted small molecules and investigational agents for Crohn's disease
- Specialized expertise in endoscopic outcome assessment and disease remission endpoints
The center's research portfolio reflects a comprehensive approach to IBD management, with particular strength in evaluating efficacy and safety profiles of emerging treatments. Their participation in studies ranging from topical rectal formulations to systemic biologics demonstrates capability in diverse trial methodologies and patient populations, positioning Gastromed S.R.L. as a key contributor to advancing therapeutic options for patients with inflammatory bowel diseases.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 2 by active trials.
- 1Janssen Cilag International2active
lock +1 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Janssen Cilag International2trials
lock +1 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 442 other sites in Romania
Therapeutic Area Benchmark — Romania
Select a therapeutic area to compare against other sites in Romania.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Romania
Market Share
Country: Romania
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Gastromed S.R.L.
lock Showing 1 of 6 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Phase 2b/3 Randomized, Double-blind, Placebo-Controlled, Parallel Group, Multicenter Protocol to Evaluate the Efficacy and Safety of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease | Janssen Cilag International | Phase IV | Recruiting | Dec 2025 | — |
IMP list
lock Showing 1 of 5 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| ICOTROKINRA | 2 | Unknown | 2025-12-03 | 2025-12-04 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.